Literature DB >> 8875991

Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase.

S Y Fuchs1, L Dolan, R J Davis, Z Ronai.   

Abstract

Ubiquitination of key cellular regulatory proteins marks them for efficient degradation via the proteasome pathway. The delta domain of c-jun is essential for its ubiquitination and also for the activating phosphorylation of neighboring serines by the stress activated jun-N-terminal kinases (JNK). Using an in vitro model system we demonstrate that JNK is among the hydrophobic binding proteins that target c-jun for efficient ubiquitination. Immunodepletion of JNK markedly inhibits c-jun ubiquitination. Conversely, c-jun ubiquitination is increased by adding purified JNK2 or extracts prepared from cells transfected with JNK2. Although c-jun ubiquitination is enhanced by JNK, the phosphorylation of c-jun on Ser73 by JNK protects c-jun from ubiquitination and prolongs its half-life. The dual activity of JNK in targeting c-jun for ubiquitination or in protecting c-jun from entering this pathway via phosphorylation points to the role of JNK in the control of c-jun stability in cells exposed to environmental stress or inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875991

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

1.  The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.

Authors:  M Pariat; C Salvat; M Bébien; F Brockly; E Altieri; S Carillo; I Jariel-Encontre; M Piechaczyk
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

Review 2.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

Review 3.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

Review 4.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

5.  Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein.

Authors:  Angela Clerk; Timothy J Kemp; Joanne G Harrison; Anthony J Mullen; Paul J R Barton; Peter H Sugden
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  Role of mitogen-activated protein kinases (MAPK) in cell injury and proliferation by environmental particulates.

Authors:  Maria E Ramos-Nino; Astrid Haegens; Arti Shukla; Brooke T Mossman
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  MEKK1/JNK signaling stabilizes and activates p53.

Authors:  S Y Fuchs; V Adler; M R Pincus; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

Review 9.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate level in cells with different p53 status.

Authors:  Sampa Ghose; Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.